Buspirone increases D2-like clopaminergic receptor density in rat striatum;Buspirona aumenta a densidade de receptores dopaminérgicos D2-símile em corpo estriado de rato

Arquivos de Neuro-Psiquiatria

Volumn 60, Issue 1, 2002, Pages 38-40

  Moreira Lima, Vera Targino ^a   Silveira Macêdo, Danielle ^a   Alves Nogueira, Carlos Renato ^a   Mendes Vasconcelos, Silvânia Maria ^a   De Barros Viana, Glauce Socorro ^a   Florenço de Sousa, Francisca Cléa ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Buspirone; Dopaminergic receptor; Striatum

Indexed keywords

BUSPIRONE; DOPAMINE 2 RECEPTOR; PARTIAL AGONIST; RADIOLIGAND; SEROTONIN 1A AGONIST; SODIUM CHLORIDE; SPIPERONE; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

EID: 0036217675     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2002000100008     Document Type: Article

References (19)

1. Neurochemical profile of buspirone
2. Notes on buspirone's mechanism of action
3. Molecular basis of buspirone's anxiolytic action
4. Clinical pharmacology of buspirone action
5. Influence of repeated treatment with buspirone on central 5-hydroxytryptamine and dopamine synthesis
6. 1A agonist
7. Pharmacology and neurochemistry of buspirone
8. 2 receptors
9. 2-and serotonin pki values
10. Protein measurement with the Folin phenol reagent
11. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug
12. Pharmacokinetics and disposition of 14C-buspirone HCI after intravenous and oral dosing in man
13. Buspirone: Chemical profile of a new class of anxioselective agents
14. Buspirone: A potential atypical neuroleptic
15. 2 dopamine binding in the rat striatum during chronic haloperidol treatment
16. Effects of buspirone on dopaminergic supersensitivite
17. Dopamine receptor antagonism by the novel anti-anxiety drug, buspirone
18. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: Comparison with buspirone
19. Climbing and stereotyped behaviours in mice require the stimulation of D1 dopamine receptors